This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Memorandum Of Agreement: Training State Regulators To Advance The Quality Of Orthopaedic Care For China

BEIJING, Nov. 14, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today signed a Memorandum of Agreement with the Beijing Drug Administration (BJDA) to jointly hold training sessions at Montagne, Zimmer's wholly-owned Chinese subsidiary.  The trainings will be dedicated to the mutual sharing of knowledge and expertise in research, development, quality and regulation related to musculoskeletal health.  The partnership aims to allow BJDA to gain industry knowledge and to understand Zimmer and its products through dialogues and trainings undertaken by its State Inspectors. The goal of the agreement also includes strengthening production and inspection expertise at Chinese medical device companies to ensure the delivery of safe and quality orthopaedic medical devices.

Under the terms of the Agreement, which is a first with the Chinese government for Zimmer, BJDA will provide the Company with professional training regarding Chinese laws and regulations related to the manufacture and sale of medical devices.  Zimmer, in turn, will share proven experience in areas including research, development, inspection, clinical use and quality systems management.  The Company is recognized internationally for the quality of its professional education training provided to surgeons through the Zimmer Institute.

"This collaboration with the Beijing Drug Administration marks a new milestone for Zimmer in China.  Worldwide, Zimmer is a recognized leader in the development of products, services and professional training that helps patients overcome pain and regain mobility," said David Dvorak, President and CEO of Zimmer.  "Cooperating with BJDA, we are strengthening our commitment to the Chinese market.  The knowledge and expertise Zimmer's employees and the State Regulators will share with one another will help to elevate orthopaedic medicine in China."

"Beijing Drug Administration is pleased that Zimmer is cooperating with us in this initiative," said Ms. Lu Aili, Deputy Director General of Beijing Drug Administration.  

"The trainings provide a platform by which both sides will be able to gain from each other's strengths related to medical devices, especially in the area of orthopaedic reconstructive.  Overall, BJDA is committed to working with all our partners and industry stakeholders to achieve the goals set forth in the 12th Five-Year Plan of upgrading the healthcare industry and ensuring citizens' health and quality of life."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,126.12 -36.87 -0.20%
S&P 500 2,120.79 -2.69 -0.13%
NASDAQ 5,097.9760 -8.6170 -0.17%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs